Liquid crystalline pharmacogel based enhanced transdermal delivery of propranolol hydrochloride

Kazierad, 1992, Beta blockers, 24 Riddel, 1987, Clinical pharmacokinetics of β-adrenoceptor antagonists, Clin. Pharmacokin., 12, 305, 10.2165/00003088-198712050-00001 Parkinson, 1996, Biotransformation of xenobiotics, 152 Shand, 1970, Plasma propranolol levels in adults with observations in four children, Clin. Pharmacol. Ther., 11, 112, 10.1002/cpt1970111112 Ogiso, 1990, Mechanism for effect of fatty acids on the percutaneous absorption of propranolol, J. Pharm. Sci., 79, 1065, 10.1002/jps.2600791206 Ahmed, 1995, Stereoselective hydrolysis and penetration of propranolol prodrugs: in-vitro evaluation using hairless mouse skin, J. Pharm. Sci., 84, 877, 10.1002/jps.2600840718 Chesnoy, 1999, Structural parameters involved in the permeation of propranolol HCl by iontophoresis and enhancers, J. Control. Rel., 58, 163, 10.1016/S0168-3659(98)00155-2 Kunita, 1997, Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin, J. Pharm. Sci., 86, 1369, 10.1021/js970161+ Schreier, 1994, Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery, J. Control. Rel., 30, 1, 10.1016/0168-3659(94)90039-6 Guy, 1992, Percutaneous penetration enhancement: physicochemical considerations and implications for prodrug design, 1 Namdeo, 2000, Spontaneous vesiculation from dry granular propharmacosome bearing propranolol hydrochloride Irwin, 1988, Drug-delivery by ion-exchange hydrolysis and rearrangement of ester prodrug of propranolol, Int. J. Pharm., 46, 57, 10.1016/0378-5173(88)90010-5 Drummer, 1981, Combined high-performance liquid chromatographic procedure for measuring 4-hydroxypropranolol and propranolol in plasma: pharmacokinetic measurements following conventional and slow release propranolol administration, J. Pharm. Sci., 70, 1030, 10.1002/jps.2600700916 Walde, 1992, Lecithin organogel as matrix for transderaml transport of drugs, J. Pharm. Sci., 81, 871, 10.1002/jps.2600810906 Wahlgren, 1984, Liquid crystals as potential ointment vehicle, J. Pharm. Sci., 73, 1484, 10.1002/jps.2600731042 Perret, 1991, A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes, J. Pharm. Pharmacol., 43, 154, 10.1111/j.2042-7158.1991.tb06657.x Rosevear, 1954, The microscopy of the liquid crystalline neat and middle phases of soaps and synthetic detergents, J. Am. Chem. Soc., 31, 628, 10.1007/BF02545595 Vora, 1998, Proniosome based transdermal delivery of levonorgestrel for effective contraception, J. Control. Rel., 54, 149, 10.1016/S0168-3659(97)00100-4 Durrheim, 1980, Permeation of hairless mouse skin I: experimental methods and comparison with human epidermal permeation by alkaloids, J. Pharm. Sci., 69, 781, 10.1002/jps.2600690709 Stroughton, 1975, 121 Yu, 1980, Physical model evaluation of topical prodrug delivery–simultaneous transport and bioconversion of vidarabine-5′-valerate V: mechanistic analysis of influence of nonhomogeneous enzyme distribution in hairless mouse skin, J. Pharm. Sci., 69, 775, 10.1002/jps.2600690708 L.G. Mueller, Novel anti-inflammatory esters, pharmaceutical composition and method for reducing inflammation, UK Pat., GB 2 204 869 A, 23 November 1988. Palagiano, 1997, In-vitro and in-vivo evaluation of terpenoid esters of indomethacin as dermal prodrugs, Int. J. Pharm., 149, 171, 10.1016/S0378-5173(97)04884-9 Finnin, 1999, Transdermal penetration enhancers: applications, limitations and potential, J. Pharm. Sci., 88, 955, 10.1021/js990154g Kobayashi, 1996, Relationship between the amount of propranolol permeating through the stratum corneum of guinea pig skin and after application of propranolol adhesive patches and skin irritation, Biol. Pharm. Bull., 19, 839, 10.1248/bpb.19.839 Code of Federal Regulations, Title 16, Part 173.210, 1976. Campbell, 1975, Dermal irritancy of metal compounds, Arch. Environ. Health, 30, 168, 10.1080/00039896.1975.10666669